Search research articles
Contact Us
Filters
Showing results (131-140 of 199) with videos related to
Page
of 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2011
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma
Tae-Ho Hwang, Anne Moon, James Burke, et al.
Science Translational Medicine
|
May 17, 2013
Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans
Mi Kyung Kim, Caroline J Breitbach, Anne Moon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2010
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
Tommy Alain, XueQing Lun, Yvan Martineau, et al.
Cancer Research
|
May 10, 2014
Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency
Alexander Muik, Lawton J Stubbert, Roza Z Jahedi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma
Nehad M Alajez, Joseph D Mocanu, Wei Shi, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcoma
Tyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Oncoimmunology
|
December 8, 2018
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
Jonathan G Pol, Sarah Lévesque, Samuel T Workenhe, et al.
Plos One
|
February 2, 2011
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors
Heather MacTavish, Jean-Simon Diallo, Baocheng Huang, et al.
Molecular Therapy Oncolytics
|
August 21, 2019
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
Adrian Pelin, Johann Foloppe, Julia Petryk, et al.
Cancers
|
October 29, 2025
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma
Tyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 199) with videos related to
Sort By:
Page
of 20
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2011
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma
Tae-Ho Hwang, Anne Moon, James Burke, et al.
Science Translational Medicine
|
May 17, 2013
Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans
Mi Kyung Kim, Caroline J Breitbach, Anne Moon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2010
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
Tommy Alain, XueQing Lun, Yvan Martineau, et al.
Cancer Research
|
May 10, 2014
Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency
Alexander Muik, Lawton J Stubbert, Roza Z Jahedi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma
Nehad M Alajez, Joseph D Mocanu, Wei Shi, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcoma
Tyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Oncoimmunology
|
December 8, 2018
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
Jonathan G Pol, Sarah Lévesque, Samuel T Workenhe, et al.
Plos One
|
February 2, 2011
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors
Heather MacTavish, Jean-Simon Diallo, Baocheng Huang, et al.
Molecular Therapy Oncolytics
|
August 21, 2019
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
Adrian Pelin, Johann Foloppe, Julia Petryk, et al.
Cancers
|
October 29, 2025
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma
Tyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Page
of 20